A carregar...

Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition–mediated cell death in K-ras mutant lung cancer cells

OBJECTIVE: There are currently no targeted therapies against lung tumors with oncogenic K-ras mutations that are found in 25% to −40% of lung cancers and are characterized by their resistance to epidermal growth factor receptor inhibitors. The isozyme group IIa secretory phospholipase A(2) (sPLA(2)I...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yu, Jessica A., Li, Howard, Meng, Xianzhong, Fullerton, David A., Nemenoff, Raphael A., Mitchell, John D., Weyant, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3855847/
https://ncbi.nlm.nih.gov/pubmed/23026567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2012.08.064
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!